Associate partners

Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (EBITDA) of about €2.8 billion. In 2011 we spent €365 million in research and development with around 2.300 employees and we have partnerships with around 300 global universities and institutions.

Scientist Dr Paul Wöbkenberg

Project Manager
Creavis - Technologies & Innovation

This email address is being protected from spambots. You need JavaScript enabled to view it.


Roughly 15% of the research and development budget is allocated to Creavis Technologies & Innovation, the strategic research and development unit of Evonik. If a research topic encompasses entirely new markets and technologies, the research is conducted at Creavis.

Creavis follows the Science-to-Business concept, which is based on the integration of all R&D activities across the value chain under one roof – starting from basic research to product development and up to pilot production. The goal is to develop new businesses up to the point of producing complete systems for the end-user. Close collaboration with universities and industry along the entire value chain is an essential part of our research strategy.